This article was originally republished from The Conversation. Bringing a new drug to market costs billions of dollars and can take over a decade. These high monetary and time investments are both ...

Human biologic drugs, including cancer-fighting antibodies, vaccines, or gene therapy targets, currently make up more than 40 percent of drug development pipelines. Biologics are designed to interact ...

CAMBRIDGE, England--(BUSINESS WIRE)--CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip, today announced it has received a grant ...